ENDV (Endonovo Therapeutics) Net Margin %: 0.00% (As of Jun. 2025)


What is Endonovo Therapeutics Net Margin %?

Endonovo Therapeutics ENDV Net Margin % is 0.00% as of Jun. 2025. The stock has 3 warning signs investors should review. Among 947 Biotechnology companies, Endonovo Therapeutics ranks worse than 105596.52% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Endonovo Therapeutics's Net Income for the three months ended in Jun. 2025 was $-0.56 Mil. Endonovo Therapeutics's Revenue for the three months ended in Jun. 2025 was $0.00 Mil. Therefore, Endonovo Therapeutics's net margin for the quarter that ended in Jun. 2025 was 0.00%.

The historical rank and industry rank for Endonovo Therapeutics's Net Margin % or its related term are showing as below:


ENDV's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -89.33
* Ranked among companies with meaningful Net Margin % only.

Endonovo Therapeutics  (OTCPK:ENDV) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Endonovo Therapeutics Net Margin % Related Terms

Endonovo Therapeutics Net Margin % Historical Data

* Premium members only.

The historical data trend for Endonovo Therapeutics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Endonovo Therapeutics Net Margin % Chart

Endonovo Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -238.55 -4,253.42 -13,685.19 4,946.43 -27,970.00

Endonovo Therapeutics Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -36,050.00 0.00 0.00 0.00 0.00

ENDV vs RGBP, IOBTQ, CNBX: Net Margin % Comparison

For the Biotechnology subindustry, Endonovo Therapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Endonovo Therapeutics Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Endonovo Therapeutics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Endonovo Therapeutics's Net Margin % falls into.


Endonovo Therapeutics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Endonovo Therapeutics's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-2.797/0.01
=-27,970.00 %

Endonovo Therapeutics's Net Margin for the quarter that ended in Jun. 2025 is calculated as

Net Margin=Net Income (Q: Jun. 2025 )/Revenue (Q: Jun. 2025 )
=-0.558/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Endonovo Therapeutics (ENDV) has a Net Margin % of 0.00% as of Jun. 2025. Net margin is the ratio of total net income to net sales. View historical data on Endonovo Therapeutics and its competitors. According to the industry distribution chart, Endonovo Therapeutics ranks #999999 out of 947 companies in the Biotechnology industry.
Is Endonovo Therapeutics' Net Margin % too high?
Endonovo Therapeutics' current Net Margin % is 0.00%. Based on the distribution chart, Endonovo Therapeutics ranks #999999 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Endonovo Therapeutics' Net Margin % compare to RGBP and IOBTQ?
According to the Biotechnology industry distribution chart, Endonovo Therapeutics ranks #999999 out of 947 companies for Net Margin %. This places Endonovo Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Endonovo Therapeutics and its competitors. Endonovo Therapeutics's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Endonovo Therapeutics stock overvalued right now?
Endonovo Therapeutics (ENDV) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Endonovo Therapeutics (ENDV), the current Net Margin % is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Endonovo Therapeutics Business Description

Address 6320 Canoga Avenue, 15th Floor, Woodland Hills, CA, USA, 91367
Endonovo Therapeutics Inc develops, manufactures and distributes revolutionary medical devices that utilize Pulsed Electro Magnetic Field (PEMF) therapy that are focused on the rapid recovery of wounds and reduction of pain, edema and inflammation on and in the human body.